...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: BIO Investor Forum

Time slots for BIO Investor Forum are now posted (times are San Francisco time). 

Resverlogix: Tuesday October 17 9:30 AM

Zenith: Wednesday October 18 11:00 AM 

Share
New Message
Please login to post a reply